3.51% -1.9783

Harrow Inc (HROW)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HROW? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Harrow Inc Stock (HROW) Company Profile

Healthcare (1117)

615.733.4731

1A BURTON HILLS BLVD, NASHVILLE, CA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

HROW's Discussions on Twitter

Vergleichen Sie HROW mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HROW Harrow Inc	49.02	1.89B	154.15M	-33.58M	-20.74M	-0.96
ZTS Zoetis Inc	126.35	55.90B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.33	51.72B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.92	44.71B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	32.07	37.30B	16.88B	666.71M	251.19M	0.6132
RGC Regencell Bioscience Holdings Ltd	50.30	20.48B	0	-5.87M	-767.30K	-0.45

Harrow Inc Stock (HROW) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-11	Eingeleitet	Cantor Fitzgerald	Overweight
2025-06-12	Eingeleitet	BTIG Research	Buy
2025-06-10	Eingeleitet	William Blair	Outperform
2025-02-06	Eingeleitet	H.C. Wainwright	Buy
2024-12-04	Bestätigt	B. Riley Securities	Buy
2024-04-11	Eingeleitet	Craig Hallum	Buy
2022-09-08	Fortgesetzt	B. Riley Securities	Buy
2021-10-14	Fortgesetzt	B. Riley Securities	Buy
2021-09-24	Eingeleitet	Aegis Capital	Buy
2021-07-02	Eingeleitet	Ladenburg Thalmann	Buy

Alle ansehen

Harrow Inc Aktie (HROW) Neueste Nachrichten

Finanzdaten der Harrow Inc-Aktie (HROW)

Harrow Inc-Aktie (HROW) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
BOLL ANDREW R.	PRESIDENT AND CFO	Dec 12 '25	Option Exercise	3.95	60,000	237,000	837,844
BAUM MARK L	CHIEF EXECUTIVE OFFICER	Dec 12 '25	Option Exercise	3.95	180,000	711,000	3,066,124
BAUM MARK L	CHIEF EXECUTIVE OFFICER	Jul 21 '25	Option Exercise	7.87	600,000	4,722,000	3,199,462
Opaleye Management Inc.	10% Owner	Jun 10 '25	Sale	30.80	15,000	462,033	90,000
Opaleye Management Inc.	10% Owner	Jun 09 '25	Sale	30.37	15,204	461,794	105,000
Opaleye Management Inc.	10% Owner	Jun 03 '25	Sale	30.04	3,000	90,116	122,000
Opaleye Management Inc.	10% Owner	Jun 04 '25	Sale	30.02	1,796	53,907	120,204
Opaleye Management Inc.	10% Owner	May 12 '25	Sale	25.90	10,000	258,959	130,000
Opaleye Management Inc.	10% Owner	May 13 '25	Sale	26.59	5,000	132,945	125,000
BOLL ANDREW R.	Chief Financial Officer	Apr 03 '25	Option Exercise	0.00	346,500	0	914,589

Harrow Inc (HROW)

Harrow Inc Stock (HROW) Company Profile

Vergleichen Sie HROW mit anderen Aktien

Harrow Inc Stock (HROW) Upgrades & Downgrades

Harrow Inc Aktie (HROW) Neueste Nachrichten

Is Harrow Inc. stock a good choice for value investorsJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - ulpravda.ru

How Harrow Inc. stock compares to growth peers2025 Short Interest & Accurate Trade Setup Notifications - ulpravda.ru

Major Harrow Health Backer Quietly Unloads a Chunk of Shares - TipRanks

Why Harrow Inc. stock remains a top recommendationMarket Growth Summary & Daily Price Action Insights - ulpravda.ru

Will Harrow Inc. stock deliver shareholder value2025 Key Lessons & Daily Stock Momentum Reports - ulpravda.ru

Harrow Health stock hits 52-week high at 54.85 USD - Investing.com

Harrow Health stock hits 52-week high at 54.85 USD By Investing.com - Investing.com India

Harrow, Inc. (HROW) Stock Analysis: Navigating a 28.88% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews

Harrow (NASDAQ:HROW) Hits New 12-Month HighWhat's Next? - MarketBeat

Harrow Health Builds Focused Ophthalmic Care Platforms - Kalkine Media

HARROW INC (NASDAQ:HROW) Emerges as a High-Growth Momentum Stock with Strong Technical Setup - Chartmill

Calamos Advisors LLC Makes New $1.09 Million Investment in Harrow, Inc. $HROW - MarketBeat

Harrow (NASDAQ:HROW) Hits New 1-Year HighTime to Buy? - MarketBeat

Harrow Health stock hits 52-week high at 51.38 USD - Investing.com

Harrow Health stock hits 52-week high at 51.38 USD By Investing.com - Investing.com UK

Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Brookstone Capital Management Grows Stock Holdings in Harrow, Inc. $HROW - MarketBeat

Harrow, Inc. $HROW Shares Sold by Rice Hall James & Associates LLC - MarketBeat

Harrow (NASDAQ:HROW) Has A Somewhat Strained Balance Sheet - 富途牛牛

Squarepoint Ops LLC Has $640,000 Stock Holdings in Harrow, Inc. $HROW - MarketBeat

First Week of February 2026 Options Trading For Harrow (HROW) - Nasdaq

Is Harrow Inc. stock vulnerable to regulatory risksJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - bolumsonucanavari.com

Will Harrow Inc. stock gain from strong economyAnalyst Downgrade & Stepwise Trade Signal Guides - Улправда

What margin trends mean for Harrow Inc. stockQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - DonanımHaber

Why Harrow Inc. stock appeals to dividend seekersJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - Улправда

Insider Buy: Can Harrow Inc. stock resist market sell offsRate Hike & Free Accurate Trade Setup Notifications - ulpravda.ru

Is Harrow Inc. stock attractive for income investorsMarket Performance Report & Consistent Growth Equity Picks - Улправда

CFO Boll Acquires 33,335 Of Harrow Inc [HROW] - TradingView — Track All Markets

Harrow (HROW) CEO Mark Baum exercises 180,000 stock options in company - Stock Titan

Harrow (NASDAQ:HROW) Trading Down 5.8%Should You Sell? - MarketBeat

Braidwell LP Trims Holdings in Harrow, Inc. $HROW - MarketBeat

Harrow (NASDAQ:HROW) Reaches New 52-Week HighWhat's Next? - MarketBeat

Harrow Health stock hits 52-week high at 50.75 USD - Investing.com

Harrow, Inc. $HROW Shares Bought by Marshall Wace LLP - MarketBeat

Precision Trading with Harrow Health Inc. 11.875% Senior Notes Due 2027 (HROWM) Risk Zones - Stock Traders Daily

Divisadero Street Capital Management LP Takes Position in Harrow, Inc. $HROW - MarketBeat

Aug Closing: Why Harrow Inc stock is favored by pension funds2025 Performance Recap & Daily Entry Point Trade Alerts - moha.gov.vn

Harrow (HROW) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

How the Narrative Surrounding Harrow Is Evolving After Analyst Target Upgrades - Yahoo Finance

Can Harrow Inc. stock deliver strong Q4 earningsLong Setup & Safe Capital Growth Stock Tips - Newser

Panagora Asset Management Inc. Acquires Shares of 47,132 Harrow, Inc. $HROW - MarketBeat

155,465 Shares in Harrow, Inc. $HROW Acquired by Diametric Capital LP - MarketBeat

Harrow (NASDAQ:HROW) Shares Up 10.2%Time to Buy? - MarketBeat

How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story - Yahoo Finance

Should Vevye’s CVS Formulary Win Prompt a Closer Look from Harrow (HROW) Investors? - simplywall.st

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS (NASDAQ:HROW) - Seeking Alpha

Creative Planning Grows Holdings in Harrow, Inc. $HROW - MarketBeat

Harrow, Inc. $HROW Shares Purchased by Geode Capital Management LLC - MarketBeat

Intech Investment Management LLC Sells 6,798 Shares of Harrow, Inc. $HROW - MarketBeat

Insider Sell: Why Harrow Inc. stock appeals to dividend seekersMarket Trend Review & Weekly High Return Stock Opportunities - moha.gov.vn

Market Trends: Is Harrow Inc. stock attractive for income investors - moha.gov.vn

Finanzdaten der Harrow Inc-Aktie (HROW)

Umsatz

Nettogewinn

Free Cashflow

ENV

Harrow Inc-Aktie (HROW) Insiderhandel

Ähnlich wie HROW